📰 Mitchell Steiner News
Page 2 - Mitchell Steiner News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mitchell Steiner. Real-time updates on events, politics, business and more.
June 11, 2023
Veru shares climbed double-digit to new highs on Monday after the oncology biopharmaceutical company released positive data on a cancer drug being studied to
May 24, 2023
24.05.2023 - MIAMI, FL, May 24, 2023 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral ARDS-related diseases, ... Seite 1
May 11, 2023
11.05.2023 - Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS), including two planned interim efficacy analyses ...
May 3, 2023
MIAMI, FL, May 03, 2023 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral... | May 3, 2023
April 20, 2023
20.04.2023 - MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related diseases, today announced the sale of its ENTADFI ... Seite 1
March 3, 2023
The U.S. Food and Drug Administration (FDA) has rejected a request to authorize a drug as a COVID-19 ...
March 2, 2023
02.03.2023 - MIAMI, FL, March 02, 2023 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced that the U.S. Food and ... Seite 1
February 9, 2023
Sabizabulin for moderate to severe COVID-19 under review for potential emergency authorization by multiple global regulatory agencies Presented late-breaker oral presentation at IDWeek; sabizabulin treatment
January 9, 2023
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of
December 17, 2022
NEW YORK, Dec. 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...